Introduction: MS-based mostly covalent binding assays precisely measure Kinact and Ki kinetics, enabling superior-throughput analysis of inhibitor potency and binding pace important for covalent drug development. each individual drug discovery scientist is aware the aggravation of encountering ambiguous data when analyzing inhibitor potency. When